← Eichor
Condition: Migraine In Children Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Migraine In Children

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · 90 location(s) · Pfizer · NCT05156398Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
Phase N/A · 3 location(s) · Danone Nutricia SpA Società Benefit · NCT06309251A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Phase 3 · 84 location(s) · H. Lundbeck A/S · NCT04965675nVNS for the Prevention and Treatment of Primary Headache
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06277063Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial
Phase 2 · 3 location(s) · University of Manitoba · NCT05337033A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Phase 1 · 13 location(s) · Pfizer · NCT06995729Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Phase 3 · 125 location(s) · Pfizer · NCT04743141Supraspinal Processing of Sensory Aspects of Pain
NA · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05814497Association of Helicobacter Pylori Infection and Migraine
NA · 1 location(s) · Sohag University · NCT06558578A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Phase 3 · 70 location(s) · H. Lundbeck A/S · NCT05164172Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase 3 · 246 location(s) · Pfizer · NCT04649242Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Phase 4 · 15 location(s) · Upsher-Smith Laboratories · NCT04748601VICO-trial: Video Consultations in the Follow-up of Children With Functional Abdominal Pain Disorders
NA · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06665867Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · 129 location(s) · AbbVie · NCT05125302
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.